Bedal International raises €10.2 million to accelerate global growth of its FlexGRIP® catheter securement devices

Bedal International, a medical device company delivering next generation catheter securement solutions, announces the successful closing of a €10.2 million funding round. The investment will be used to support the company’s ongoing global growth.

The funding round was led by White Fund, a Belgian MedTech venture capital fund, and SFPIM, the sovereign wealth fund of Belgium. The round also saw participation from U.S.-based MedTech investors, as well as Bedal’s leading existing investors, F3 Finance and LRM. The management team of Bedal also contributed to this funding round.

“Since we founded Bedal, it has already been an incredible journey from launching the devices to growing into a global presence.” said Alexander Van Damme, CEO of Bedal International. “This new funding marks the beginning of a next chapter for us, focused on setting a new worldwide standard for catheter comfort and securement.”

Bedal markets the FlexGRIP® catheter securement devices, which secure catheters of all sorts (e.g. vascular, urinary, drainage), reducing the risk of complications and improving overall patient outcomes. The FlexGRIP devices are in use in more then 34 countries globally, and Bedal has succesfully closed global deals with market leading catheter companies. The additional funding will allow Bedal to expand its operations and commercial efforts, with a strong focus on further growth in the US market.

“White Fund and SFPIM are excited to support Bedal’s mission to improve patient care through its innovative devices,” said Eric Brandt of White Fund, Céline Vaessen, CIO at SFPIM also adds “We believe in Bedal’s potential to become the golden standard for catheter care. We are proud to be part of their promising growth journey and are committed to supporting their product development engine with the ambition of making a profound impact on the lives of patients and caregivers.”

Previously, Bedal also attracted an industry veteran, Steve Bierman, MD, who was the original creator of the industry and developed the catheter securement market. Dr. Bierman has taken on the role of co-CEO, bringing his extensive experience and vision to the company.

Bedal was founded based on the experiences of one of the founders, who discovered the challenges of catheter care during his cancer treatment. The FlexGRIP devices are used hospital-wide in applications such as cancer treatment, post operative care and the Intensive care unit. Recently, Bedal also launched a pediatric range of products, tailored to the needs of young patients.

In the press:
Article in De Tijd